|
시장보고서
상품코드
2080207
흡입용 일산화질소 시장 : 제품 유형별, 연령층별, 용도별, 최종사용자별, 지역별Inhaled Nitric Oxide Market, By Product Type, By Age Group, By Application, By End User, By Geography |
||||||
흡입용 일산화질소 시장 규모는 2026년에 16억 6,760만 달러로 추정되고 있으며, 2033년까지 30억 2,140만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.9%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 16억 6,760만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.90% | 2033년 시장 규모 예측 : | 30억 2,140만 달러 |
흡입형 일산화질소는 폐 혈관 확장제로서 선택적으로 작용하는 약물로, 폐 혈관을 이완시켜 환기가 원활한 부위로의 혈류를 개선합니다. 이 약제는 주로 중환자 치료 현장에서 투여되며, 신생아 지속성 폐고혈압증으로 인한 신생아 저산소성 호흡부전 치료에 널리 사용되고 있습니다. 또한 급성 호흡곤란 증후군, 폐고혈압증, 그리고 심장·흉부 수술에 따른 합병증의 치료에도 사용됩니다. 호흡기 질환은 증가 추세를 보이고 있으며, 의료 분야에서 중환자 치료에 대한 의존도도 높아지고 있습니다.
흡입용 일산화질소 투여 시스템 분야에서는 휴대성, 투여량의 정확도, 인공호흡기와의 호환성에 관한 혁신이 진행되고 있습니다. 일산화질소 생산 분야에서 탱크가 필요 없는 온디맨드형 시스템으로의 전환은 일산화질소 가스통 취급으로 인한 제한을 극복하는 동시에 이 기술을 보다 쉽게 활용할 수 있도록 돕습니다. 또한 개발도상국에서의 신생아 및 중환자실(ICU) 시설 확충도 시장 역학에 긍정적인 영향을 미치고 있습니다. 그러나 높은 비용과 다른 호흡 관리 요법의 존재가 일산화질소 제품의 시장 침투를 저해하는 요인으로 작용하고 있습니다. 그렇긴 하지만, 현재의 임상 연구를 통해 밝혀진 잠재적인 응용 분야만으로도 이 시장의 향후 성장을 보장하기에 충분하다고 볼 수 있습니다.
시장 역학
전 세계 흡입형 일산화질소 시장은 중증 호흡기 질환의 유병률 증가와 집중 치료법의 보급에 힘입어 인상적인 성장을 달성하고 있습니다. 이 치료법은 호흡 곤란을 겪는 중증 환자에게 산소를 공급하는 효과적인 수단으로서 널리 받아들여지고 인정받고 있습니다. 조산아의 증가와 신생아 집중치료실(NICU)의 확충은 본 제품의 수요가 꾸준히 증가하고 있는 요인 중 일부입니다. 또한 호흡곤란 증후군, 폐고혈압, 심폐 질환의 유병률 증가 역시 흡입형 일산화질소의 도입을 촉진하는 데 중요한 역할을 하고 있습니다.
그러나 시장의 대폭적인 확장을 저해할 가능성이 있는 몇 가지 요인이 있습니다. 그 중 하나는 치료나 장비 비용이 고액이기 때문에 예산에 제약이 있는 의료 시설 이용자들에게는 도입이 어렵다는 점입니다. 또한 환자의 호흡 보조 및 기타 병세 개선을 돕는 대안으로서, 업계에는 경쟁 관계에 있는 다른 기술들도 존재합니다. 그 밖의 과제로는 가스의 보관 및 수송의 어려움이 꼽히며, 이는 일부 의료 시설에서 이 기술의 도입을 저해하는 요인이 될 수 있습니다. 그러나 업계 내에서는 일산화질소를 공급하기 위한 휴대용 제품이나 탱크가 없는 방식의 등장 등 몇 가지 유망한 동향이 나타나고 있습니다. 이러한 추세는 시장내 도입 장벽, 특히 보관 및 휴대성과 관련된 문제를 극복하는 계기가 될 것입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 흡입형 일산화질소 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- '세계의 흡입형 일산화질소 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 흡입용 일산화질소 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 흡입용 일산화질소 시장 : 제품 유형별, 2021-2033년
제5장 세계의 흡입용 일산화질소 시장 : 연령층별, 2021-2033년
제6장 세계의 흡입용 일산화질소 시장 : 용도별, 2021-2033년
제7장 세계의 흡입용 일산화질소 시장 : 최종사용자별, 2021-2033년
제8장 세계의 흡입용 일산화질소 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.07.10Inhaled Nitric Oxide Market is estimated to be valued at USD 1,667.6 Mn in 2026 and is expected to reach USD 3,021.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,667.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 3,021.4 Mn |
Inhaled nitric oxide is an agent that acts selectively as a vasodilator for the lungs, it relaxes the pulmonary vasculature, thus improving the blood flow into areas of good ventilation. This drug is administered mainly in intensive care settings and is commonly used in the management of neonatal hypoxic respiratory failure due to persistent pulmonary hypertension of the newborns. It is also indicated in acute respiratory distress syndrome, pulmonary hypertension, and complications from cardiac and thoracic surgeries. Respiratory diseases have been on the increase, while the dependence on intensive care medicine has also grown in the health care sector.
Inhaled nitric oxide administration systems are experiencing innovations related to their mobility, dose accuracy, and ventilator compatibility. The move towards tank-free and demand-based systems for nitric oxide production can help in making the technology easily accessible while overcoming limitations arising from the handling of nitric oxide gas cylinders. Besides, the development of neonatal and ICU facilities in the developing nations is contributing positively to market dynamics. Yet, high costs involved and the presence of other respiratory management therapies pose restrictions in the market penetration of nitric oxide products. Nevertheless, the potential applications discovered through current clinical studies should be sufficient to ensure future growth in this market.
Market Dynamics
The global inhaled nitric oxide market has witnessed a significant growth due to the growing prevalence of critical respiratory illnesses and the use of intensive care treatment methods. The therapy is widely accepted and recognized as an effective means of oxygenating critical patients who suffer from respiratory distress. The increasing numbers of babies born prematurely and neonatal intensive care units are some of the factors that have been contributing to a consistent increase in the demand for the product. Furthermore, the growing prevalence of respiratory distress syndrome, pulmonary hypertension, and cardiopulmonary disorders is playing an instrumental role in driving the uptake of inhaled nitric oxide.
However, several aspects could hinder the market from experiencing any significant expansion. These include the expensive nature of treatment and equipment, making it difficult for users in healthcare facilities with cost constraints to afford. Besides, there are other techniques available in the industry that act as competition in providing alternatives to assist patients in respiration and other medical conditions. Other challenges include the difficulties in storing and transporting gases, which can be an obstacle in adopting the technology in some health facilities. However, several promising trends exist within the industry, such as the emergence of portable and tankless methods for delivering nitric oxide. This trend will overcome some barriers to adoption within the market, especially those concerning storage and portability.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global inhaled nitric oxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Linde plc, Air Liquide, VERO Biotech, Beyond Air, Bellerophon Therapeutics, Getinge AB, Nu-Med Plus, International Biomedical, and Messer Group
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global inhaled nitric oxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled nitric oxide market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Inhaled Nitric Oxide Delivery Systems
- Consumables
- Age Group Insights (Revenue, USD Mn, 2021 - 2033)
- Neonates
- Pediatrics
- Adults
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn)
- Acute Respiratory Distress Syndrome (ARDS)
- Pulmonary Hypertension
- Surgery and Postoperative Management
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Mallinckrodt Pharmaceuticals
- Linde plc
- Air Liquide
- VERO Biotech
- Beyond Air
- Bellerophon Therapeutics
- Getinge AB
- Nu-Med Plus
- International Biomedical
- Messer Group
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Inhaled Nitric Oxide Market, By Product Type
- Global Inhaled Nitric Oxide Market, By Age Group
- Global Inhaled Nitric Oxide Market, By Application
- Global Inhaled Nitric Oxide Market, By End User
- Global Inhaled Nitric Oxide Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Inhaled Nitric Oxide Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Inhaled Nitric Oxide Delivery Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Inhaled Nitric Oxide Market, By Age Group, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Inhaled Nitric Oxide Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pulmonary Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Surgery and Postoperative Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Inhaled Nitric Oxide Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Inhaled Nitric Oxide Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Linde plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Air Liquide
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VERO Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beyond Air
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bellerophon Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nu-Med Plus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- International Biomedical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Messer Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
